Nyhetsartiklar inom ämnet: oncoinvent

• Torsdag den 5 december

  11:00
• 11:53 Oncoinvent ASA announces oversubscribed private placement

• Måndag den 11 november

  08:00
• 08:50 Oncoinvent Announces Promising Interim Results for Radspherin® as a Potential Treatment for Peritoneal Carcinomatoses

• Torsdag den 10 oktober

  11:00
• 11:10 Oncoinvent Announces First Patient Dosed in its Phase 2 Clinical Trial of Radspherin® in Ovarian Cancer Patients